Safety Evaluation of Propofol Sedation for Magnetic Resonance Imaging in Pediatric Patients
- Conditions
- Multiparametric Magnetic Resonance ImagingPropofol Adverse ReactionSedation ComplicationAnesthesia; Adverse Effect
- Registration Number
- NCT04455776
- Lead Sponsor
- Brugmann University Hospital
- Brief Summary
Propofol is often used for sedation in children undergoing magnetic resonance imaging. The investigators will perform a chart review of 4 month of activity (about 100 cases) and review the incidence and severity of adverse events of this sedation technique.
- Detailed Description
Magnetic resonance imaging in children, especially under 6 years of age, is often performed under sedation. Propofol is a common drug used in this settings. In our institution, sedation is most often done by a propofol bolus of 2-5 mg/kg in order to reach a deep level of sedation as defined by Coté et al. If judged necessary by the attending anaesthesiologist, a additional propofol bolus of 0.5-1 mg/kg may be given. For longer lasting exams, the attending anaesthesiologist can chose to use a continuous infusion of propofol. The investigators will review the charts of 4 month of magnetic resonance imaging, which will give us a cohort of about 100 patients. Baseline characteristics, detailed sedation technique used will be recorded. Adverse events defined as:
* Oxygen desaturation measured by transcutaneous oximetry SpO2≤94%
* hypercapnia measure by end-tidal CO2 \>45 mm Hg
* movement of the patient
Assuming a non-normal distribution (tested by a Kolmogorov-Smirnov test), variables will be reported as median and interquartile range. Statistical tests will be done by non-parametric tests, Mann Whitney U. Non continuous variables will be analyzed by a Chi-square test.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 99
- Pediatric patients scheduled for MRI under sedation by an anaesthesiologist
- Age < 16 years
- Age > 16 years
- Sedation performed by a non-anesthesiologist
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hypoxemia 90 minutes Arterial desaturation defined as number of episodes with an SpO2≤94%
Hypercapnia 90 minutes Hypercapnia, defined as number of episodes with an ETCO2 \> 45 mm HG
Movements 90 minutes Number of patient movements interfering with the MRI exam
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Hôpital Universitaire des Enfants Reine Fabiola
🇧🇪Brussels, Belgium